Ondansetron
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
85534-0063 -
Package NDC
85534-0063-0 -
Package NDC
85534-0063-1 -
Package NDC
85534-0063-2 -
Application number
ANDA090469 -
SPL ID
56c8d16e-03c0-e990-e063-6294a90a0b76 -
SPL set ID
b76c5cc9-f1ca-428b-8989-36a66802b650 -
UNII
4AF302ESOS -
RxCUI
104894 -
RxCUI
312087
What the source publishes
- Labeler
- HAWAII REPACK, INC.
- Active ingredients
- Ondansetron
- Form
- TABLET, ORALLY DISINTEGRATING
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Ondansetron",
"splId": "56c8d16e-03c0-e990-e063-6294a90a0b76",
"labels": [
{
"setId": "b76c5cc9-f1ca-428b-8989-36a66802b650",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b76c5cc9-f1ca-428b-8989-36a66802b650",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b76c5cc9-f1ca-428b-8989-36a66802b650"
}
],
"routes": [
"ORAL"
],
"labeler": "HAWAII REPACK, INC.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (85534-0063-0)",
"package_ndc": "85534-0063-0",
"identifierStatus": "well-formed",
"marketing_start_date": "20260717"
},
{
"sample": false,
"description": "20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (85534-0063-1)",
"package_ndc": "85534-0063-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20260717"
},
{
"sample": false,
"description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (85534-0063-2)",
"package_ndc": "85534-0063-2",
"identifierStatus": "well-formed",
"marketing_start_date": "20260717"
}
],
"productId": "85534-0063_56c8d16e-03c0-e990-e063-6294a90a0b76",
"useDomain": "unknown",
"dosageForm": "TABLET, ORALLY DISINTEGRATING",
"productNdc": "85534-0063",
"deaSchedule": null,
"genericName": "Ondansetron",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ONDANSETRON",
"strength": "8 mg/1"
}
],
"applicationNumber": "ANDA090469",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20100412",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175817",
"N0000175818"
],
"unii": [
"4AF302ESOS"
],
"rxcui": [
"104894",
"312087"
],
"spl_set_id": [
"b76c5cc9-f1ca-428b-8989-36a66802b650"
],
"pharm_class_epc": [
"Serotonin-3 Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"Serotonin 3 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"HAWAII REPACK, INC."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:85534-0063_56c8d16e-03c0-e990-e063-6294a90a0b76"